1. Home
  2. AEVA vs MGTX Comparison

AEVA vs MGTX Comparison

Compare AEVA & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeva Technologies Inc.

AEVA

Aeva Technologies Inc.

HOLD

Current Price

$10.20

Market Cap

1.1B

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$9.22

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEVA
MGTX
Founded
2019
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
AEVA
MGTX
Price
$10.20
$9.22
Analyst Decision
Buy
Buy
Analyst Count
5
8
Target Price
★ $29.00
$27.75
AVG Volume (30 Days)
★ 1.4M
900.2K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
10.53
★ 33.02
EPS
N/A
★ 1.30
Revenue
N/A
★ $81,391,000.00
Revenue This Year
$78.97
$314.19
Revenue Next Year
$124.76
N/A
P/E Ratio
★ N/A
$7.51
Revenue Growth
N/A
★ 144.57
52 Week Low
$8.83
$6.62
52 Week High
$31.30
$15.35

Technical Indicators

Market Signals
Indicator
AEVA
MGTX
Relative Strength Index (RSI) 29.81 31.78
Support Level N/A $8.84
Resistance Level $16.49 $10.06
Average True Range (ATR) 0.76 0.53
MACD -0.16 0.01
Stochastic Oscillator 12.48 3.63

Price Performance

Historical Comparison
AEVA
MGTX

About AEVA Aeva Technologies Inc.

Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The 4D LiDAR sensors are designed to detect both velocity and position, supporting perception and decision-making in automated systems. The company operates in North America, EMEA, and Asia. The company's revenue consists of sales of perception solutions or sensing systems and non-recurring engineering services. Geographically, it derives the majority of its revenue from North America.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: